AGP Picks
View all

Georgian Technology News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Georgian Technology News.

Press releases published on November 19, 2026

Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
Communiqué de presse : VaxRabeo, le vaccin contre la rage de nouvelle génération de Sanofi, approuvé dans l’UE pour tous les âges
Noitom Robotics Ranked No. 1 in Asia on The Information's 50 Most Promising Startups of 2026
诺亦腾机器人入选 The Information 2026 全球最具潜力50家初创企业榜单
Honeywell Aerospace Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Honeywell Aerospace, Inc. - HONA
SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering
Gildan Activewear Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gildan Activewear Inc. - GIL
Duolingo Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Duolingo, Inc. - DUOL
Everest Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Everest Group, Ltd. - EG
Millrose Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Millrose Properties, Inc. - MRP
Ensign Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Ensign Group, Inc. - ENSG
Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
JOYY Reports Third Quarter 2026 Unaudited Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Georgian Technology News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.